Group B Strep (GBS) Neonatal Infection

Group B Streptococcus is one of those medical terms that can send expectant parents into a spiral of late-night internet searches. The bacteria itself is actually quite common, living harmlessly in about 1 in 4 pregnant women. But when it is transmitted to a newborn, it can cause serious infections that require immediate medical attention.

Understanding GBS and how it affects newborns means understanding both the real risks and the effective prevention strategies that have dramatically improved outcomes over the past few decades. This isn’t about creating fear. It’s about having the information you need to recognize potential warning signs if your baby does develop an infection and understanding how modern obstetric care works to prevent transmission in the first place.

What Is Group B Strep?

Group B Streptococcus is a type of bacteria that naturally lives in the gastrointestinal and genitourinary tracts of many healthy adults. Carrying GBS doesn’t mean someone is sick or has an infection. It’s simply part of the normal bacterial ecosystem in their body.

The bacteria can come and go. A woman who tests positive during one pregnancy might test negative during another. This transient nature is part of why testing happens late in pregnancy rather than during early prenatal visits.

GBS becomes medically significant during pregnancy because it can be transmitted to a baby during labor and delivery. The bacteria that cause no problems in an adult can overwhelm a newborn’s immature immune system, leading to potentially severe infections.

How Babies Get GBS Infections

Babies typically acquire GBS through vertical transmission, meaning the bacteria passes from mother to baby. This most commonly happens during labor and delivery as the baby moves through the birth canal where GBS bacteria may be present.

Less commonly, babies can acquire GBS before birth if there’s prolonged rupture of membranes or if the bacteria ascend into the amniotic fluid. This is one reason why prolonged membrane rupture is considered a risk factor even when GBS status is unknown.

For late onset infections that develop after the first week of life, the source can be more varied. While some cases still trace back to maternal colonization, others may come from hospital environments or community exposure.

Early Onset GBS Disease

Early onset disease develops within the first week of life, with most cases appearing in the first 24 to 48 hours. This timing reflects the fact that these infections stem from exposure during labor and delivery.

About 69% of early onset cases present as sepsis, which is a bloodstream infection that can affect the entire body. Pneumonia is another common manifestation, and occasionally babies develop meningitis, though that’s more typical of late onset disease.

Symptoms Parents and Medical Staff Watch For

Respiratory distress is often the first noticeable sign. The baby might breathe rapidly, grunt with breathing, or have visible retractions where the skin pulls in between the ribs or around the collarbone with each breath.

Temperature instability can go either direction. Some babies have a fever, but others actually become hypothermic and can’t maintain normal body temperature.

Lethargy and poor feeding are red flags in any newborn, but they’re particularly concerning in the first few days of life. A baby who won’t wake for feeds or is too weak to eat effectively needs immediate evaluation.

Other concerning signs include irritability, jaundice appearing in the first 24 hours (which is always abnormal), and in severe cases, low blood pressure or shock.

Late Onset GBS Disease

Late onset disease develops anywhere from 7 days to three months of age, though most cases occur within the first month. The presentation differs somewhat from early onset disease.

Meningitis is more common with late onset GBS, occurring in a significant portion of cases. This means the bacteria have invaded the protective membranes surrounding the brain and spinal cord, leading to inflammation that can cause both immediate danger and long term complications.

The symptoms of late onset disease often develop more gradually than early onset sepsis. Parents might notice increasing fussiness, feeding difficulties, or changes in the baby’s activity level over hours or days.

Because late onset disease occurs after the typical newborn hospital stay, parents need to trust their instincts if something seems wrong. Any fever in an infant under three months requires immediate medical evaluation, as does unusual lethargy, irritability that does not resolve with feeding or comforting, or any concerning change in breathing.

Risk Factors for GBS Neonatal Infection

Maternal GBS colonization is the primary risk factor. When a mother carries GBS and doesn’t receive appropriate antibiotics during labor, her baby has roughly a 1 in 100 chance of developing early onset disease. With proper antibiotic treatment during labor, that risk drops to about 1 in 300.

Preterm labor significantly increases risk because babies born before 37 weeks have less developed immune systems and are more vulnerable to all infections. Additionally, preterm labor may not allow time for screening or antibiotic administration.

Prolonged rupture of membranes, typically defined as more than 18 hours before delivery, increases the window during which bacteria can potentially reach the baby.

Fever during labor or chorioamnionitis (infection of the amniotic membranes) suggests that bacteria may already be present in the uterine environment, raising serious concerns about potential fetal exposure.

A previous baby with GBS disease substantially increases risk for future pregnancies. This history means the mother will automatically receive antibiotics during labor regardless of screening results.

For late onset disease, additional risk factors emerge. Younger maternal age, certain ethnic backgrounds, and HIV exposure have all been associated with increased rates of late onset infection, suggesting complex interactions between immunity, bacterial transmission, and environmental factors.

GBS Screening During Pregnancy

The standard approach in the United States involves universal screening of all pregnant women between 36 weeks and 37 weeks 6 days of gestation. This timing matters because it’s close enough to delivery that colonization status is likely to remain accurate, but early enough to ensure results are available before labor begins.

The screening itself is straightforward. A healthcare provider collects swab samples from the vagina and rectum. These samples go to a lab where they’re cultured to see if GBS bacteria grow. Results typically return within a few days.

This universal screening approach replaced an earlier risk-based strategy that only tested women with certain risk factors. The universal approach catches more cases because many women who carry GBS have no identifiable risk factors.

When Screening Results Aren’t Available

Sometimes labor begins before screening happens or before results come back. In these situations, providers use risk-based protocols. If any significant risk factors are present, such as fever during labor, preterm labor, or prolonged membrane rupture, antibiotics are started as a precaution.

If labor begins prematurely but no other risk factors exist, decisions about antibiotics become more nuanced and depend on specific circumstances and how many weeks along the pregnancy is.

Intrapartum Antibiotic Prophylaxis

Intrapartum antibiotic prophylaxis, or IAP, means giving antibiotics intravenously during labor to prevent GBS transmission. This intervention is remarkably effective and has reduced early onset GBS disease rates by more than 80% since it became standard practice.

The preferred antibiotic is penicillin, given through an IV every four hours during labor. Ampicillin is an acceptable alternative. The goal is to get at least one dose into the mother’s system at least four hours before delivery, giving the antibiotic time to reach effective levels in the baby’s bloodstream.

Why Timing Matters

Antibiotics given before labor begins don’t provide protection. GBS can recolonize the vaginal tract quickly after antibiotic treatment stops, which is why treatment must happen during labor when there’s continuous antibiotic presence until delivery.

Very rapid labors present a challenge. If delivery happens within less than four hours of starting antibiotics, the baby may not receive full protection. These babies typically receive closer clinical observation after birth, though they may not require treatment if they appear healthy and have no other risk factors.

Penicillin Allergies

Penicillin allergies complicate antibiotic selection because alternative antibiotics aren’t quite as effective and GBS has developed resistance to some options.

For women with low-risk penicillin allergies who’ve never experienced anaphylaxis or severe reactions, cefazolin is typically used. It’s from a related antibiotic family but usually safe for people with mild penicillin reactions.

For women with high-risk penicillin allergies who’ve experienced anaphylaxis or other serious reactions, the choices narrow. Clindamycin was traditionally used, but increasing resistance rates mean that GBS bacteria must now be tested to confirm they’re susceptible to clindamycin before it’s relied upon. If the bacteria are resistant or susceptibility testing wasn’t done, vancomycin becomes the option.

What Happens When a Baby Develops GBS Infection

Suspected GBS infection triggers an immediate and aggressive medical response. The baby will be admitted to the Neonatal Intensive Care Unit where specialized equipment and round-the-clock monitoring are available.

Blood cultures are drawn to identify whether bacteria are present in the bloodstream and, if so, which species. A complete blood count looks for signs of infection, such as elevated or abnormally low white blood cells. A chest X-ray evaluates for pneumonia.

If meningitis is suspected based on symptoms or if the baby appears seriously ill, a lumbar puncture (spinal tap) will be performed to examine the cerebrospinal fluid for bacteria and signs of inflammation.

Treatment begins before culture results return because waiting 24 to 48 hours for bacterial growth could be catastrophic. Broad-spectrum intravenous antibiotics, typically ampicillin combined with gentamicin, are started immediately. These antibiotics work against GBS and other bacteria that could potentially be causing similar symptoms.

Duration of Treatment

If blood cultures come back positive for GBS, treatment continues for at least 10 days. Babies with meningitis require even longer treatment, typically 14 days or more, because the infection is harder to clear from the central nervous system.

Babies whose cultures remain negative but who were showing concerning symptoms might receive a shorter course of antibiotics, often 48 to 72 hours, until infection is definitively ruled out.

Throughout treatment, the baby receives supportive care. This might include respiratory support ranging from supplemental oxygen to mechanical ventilation for babies with severe pneumonia. Intravenous fluids maintain hydration and provide nutrition until the baby can feed normally. Blood pressure support might be needed if sepsis has caused shock.

Potential Complications and Long Term Effects

The severity of GBS infection varies enormously. Some babies respond quickly to antibiotics with no lasting effects. Others face serious complications that impact them throughout life.

Mortality rates have declined substantially with modern treatment but still range from 5% to 10% overall. Very premature or very low birthweight babies face higher risks, with mortality rates up to 30% in some studies.

Meningitis creates the highest risk for permanent neurological damage. The inflammation in and around the brain can cause hearing loss, vision problems, developmental delays, cerebral palsy, and seizure disorders. Some children with GBS meningitis require lifelong medical care and support.

Even without meningitis, severe sepsis can cause complications. Lung damage from pneumonia occasionally leads to chronic respiratory problems. Septic shock can cause organ damage affecting the kidneys, liver, or other systems.

The outcomes are difficult to predict during acute illness. Some babies who appear critically ill make complete recoveries, while others have complications that only become apparent as they grow and miss expected developmental milestones.

Observing Healthy Babies with Risk Factors

Not every baby with risk factors develops infection. Guidelines exist for how closely to observe babies who were exposed to risk factors but appear healthy at birth.

A baby whose mother received adequate IAP for documented GBS colonization and who appears completely well typically requires only routine observation. Parents and nursing staff watch for any signs of infection during the normal newborn hospital stay.

Babies whose mothers had chorioamnionitis or other higher risk scenarios might undergo limited evaluation with blood tests and 48 hours of observation at minimum. Some may receive preventive antibiotics for a short course even if they appear well.

Babies who develop any symptoms consistent with possible infection receive a full sepsis evaluation regardless of their risk factors or how minor the symptoms might seem. A subtle early symptom like increased breathing rate can progress rapidly in newborns, so the threshold for evaluation is intentionally low.

Prevention Efforts Have Made a Difference

The implementation of universal screening and intrapartum antibiotic prophylaxis represents one of the major success stories in obstetric and neonatal care over the past 30 years. Early onset GBS disease rates have dropped by more than 80% since these protocols became standard.

In the early 1990s, before widespread screening and IAP, early onset GBS disease affected about 1.7 per 1,000 live births. By the 2010s, that rate had fallen to roughly 0.23 per 1,000 births. Thousands of cases of serious neonatal infections have been prevented.

Late onset disease rates have not declined as dramatically because these infections often don’t stem directly from labor and delivery exposure. This is an area of ongoing research and concern.

What Still Needs Improvement

Despite remarkable progress, GBS remains the leading cause of early onset neonatal sepsis in developed countries. The current prevention strategy, while effective, isn’t perfect.

Some babies still develop early onset disease even when mothers received appropriate antibiotics. Rapid labors that don’t allow adequate time for antibiotic administration account for some cases. Others occur despite seemingly adequate treatment, possibly due to antibiotic resistance, unusually high bacterial loads, or variations in how individuals respond to antibiotics.

The antibiotics used during labor aren’t specific to GBS. They affect the mother’s and baby’s entire microbiome, potentially disrupting beneficial bacteria. Whether this has long term health implications remains an area of active research.

The Promise of Vaccination

A GBS vaccine has been in development for years and could potentially provide better protection than antibiotics during labor. If pregnant women were vaccinated, they would produce antibodies against GBS that would pass to their babies, providing protection that lasts beyond the immediate birth period.

Several vaccine candidates are in various stages of clinical trials. Success would be particularly meaningful for late onset disease, which current strategies don’t effectively prevent, and for settings where screening and intrapartum antibiotics aren’t readily available.

Global Health Perspective

Most of the available data on GBS and prevention strategies comes from high-income countries with well-developed healthcare systems. The picture looks quite different globally.

In areas where universal screening and intrapartum antibiotics aren’t standard or available, GBS disease rates remain much higher. Some estimates suggest that GBS causes over 90,000 infant deaths worldwide each year, with the vast majority occurring in low and middle-income countries.

Resource limitations mean many women don’t receive prenatal care that includes GBS screening. Even when colonization is known, sterile conditions for delivery and access to intravenous antibiotics cannot be guaranteed.

This global burden emphasizes why vaccine development matters so much. A vaccine that could be given during routine prenatal care would protect babies regardless of where or how they’re born.

Understanding the Medical Terminology

The medical language around GBS infection can feel overwhelming, especially when you’re processing information quickly in a stressful situation.

Sepsis means bacteria have entered the bloodstream and are causing a systemic response throughout the body. The immune system’s reaction to the infection can be as dangerous as the bacteria themselves.

Meningitis is inflammation of the meninges, the protective membranes covering the brain and spinal cord. It’s diagnosed by examining cerebrospinal fluid obtained through a lumbar puncture.

Pneumonia indicates infection and inflammation in the lungs. In newborns, this typically causes rapid breathing, grunting, or more visible work of breathing.

Prophylaxis simply means prevention. Antibiotic prophylaxis means giving antibiotics to prevent infection rather than to treat an existing infection.

Colonization describes when bacteria are present but not causing infection. Being colonized with GBS isn’t itself harmful, but it creates transmission risk.

When Medical Care May Have Fallen Short

The established protocols for GBS screening and prevention are clear and well documented. When these protocols aren’t followed and a baby develops preventable GBS infection, it raises questions about whether appropriate care was provided.

Failures in GBS prevention might include not performing screening at the recommended time, losing or failing to communicate test results, not administering antibiotics when screening was positive, or not recognizing risk factors that should have triggered treatment even without positive screening.

Similarly, delays in recognizing or treating a baby who develops symptoms of infection can allow the disease to progress to a more severe state than necessary.

Not every case of GBS disease represents a failure in medical care. Even with perfect adherence to protocols, some infections still occur. But when standard practices weren’t followed, families deserve answers about why that happened and whether it made a difference in their baby’s outcome.

Living with the Aftermath

For families whose babies developed serious GBS infections, the medical crisis is just the beginning of a much longer journey. A baby with permanent neurological damage will require ongoing therapy, medical care, specialized equipment, and potentially lifelong support.

Hearing loss from meningitis might mean learning sign language, getting cochlear implants, and working with audiologists and speech therapists for years. Developmental delays require early intervention services, special education, and constant advocacy to ensure the child gets necessary support.

Cerebral palsy can range from mild motor difficulties to severe impairment requiring wheelchair use, feeding tubes, and intensive physical care. Some children need multiple surgeries to address complications.

The financial implications extend far beyond medical bills. One parent may need to reduce work hours or stop working entirely to manage medical appointments and caregiving. Specialized childcare, home modifications, and medical equipment create ongoing expenses that insurance may not fully cover.

The emotional toll affects entire families. Guilt, grief, and trauma are common even when no one did anything wrong. When preventable errors contributed to the injury, those feelings intensify and may complicate the healing process.

Moving Forward

Understanding GBS neonatal infection means understanding both a significant medical risk and the powerful prevention tools that have dramatically reduced that risk over recent decades.

For most pregnant women, GBS screening is a routine part of prenatal care: the provider screens, the results are communicated, and if needed, antibiotics are given during labor. In the vast majority of cases, this process works as intended, and babies are born healthy.

When complications do occur, knowing about GBS helps families understand what’s happening, what questions to ask, and what to expect. The medical terminology becomes less frightening when you understand what it actually means.

The continued research into better prevention strategies, the development of vaccines, and the efforts to extend life-saving protocols to all populations worldwide show that this remains an active area of medical progress. What we know and can do today is dramatically better than even 20 years ago, and further improvements are coming.

For families dealing with the aftermath of GBS infection, understanding the medical facts is just one piece of a much larger puzzle. But it’s an important piece, providing context for medical decisions, long-term planning, and when necessary, determining whether the care provided met established standards.